Tirzepatide Cost Comparison
Questions for comparing tirzepatide quotes, insurance or manufacturer-program requirements and the full terms of a care plan.
Editorial update: October 30, 2026 (UTC). This is not a new clinical review or a verification of current manufacturer offers.
How much does compounded tirzepatide cost through Trimi?
Compounded tirzepatide prescribed through Trimi is $235 billed monthly, $597 billed every 3 months ($199 a month equivalent), $1,050 upfront for 6 months ($175 a month equivalent), or $1,500 upfront for a 12-month commitment ($125 a month equivalent). A prepaid monthly equivalent is not a monthly charge.
The table below covers Trimi's own compounded plans. Manufacturer offers, insurance benefits and other care programs have separate eligibility and payment terms; this table does not establish savings or clinical equivalence to a brand-name prescription.
| Plan | Compounded semaglutide | Compounded tirzepatide |
|---|---|---|
| Monthly | $175 billed monthly$175 a month | $235 billed monthly$235 a month |
| Quarterly, 3-month commitment | $435 billed every 3 months$145 a month equivalent | $597 billed every 3 months$199 a month equivalent |
| 6-month, 6-month commitment | $720 billed upfront$120 a month equivalent | $1,050 billed upfront$175 a month equivalent |
| Annual, 12-month commitment | $1,188 billed upfront$99 a month equivalent | $1,500 billed upfront$125 a month equivalent |
Plan sources checked October 30, 2026 (UTC). Sources: semaglutide plans, tirzepatide plans and the refund policy. Compounded medications are not FDA-approved; FDA compounding questions and answers, checked October 30, 2026 (UTC).
Brand-Name Pricing and Access
Retail quotes, manufacturer programs and insurance benefits have different conditions. A price listing does not establish your coverage or eligibility. Check the current quote and its terms, including GoodRx pricing data.
Read the current Mounjaro savings card eligibility, coverage and expiry conditions directly. This guide does not certify that a particular patient qualifies or that a past offer remains available.
General insurance research, including the Kaiser Family Foundation analysis, does not establish the formulary, prior authorization rules or out-of-pocket costs of your individual plan. Verify those with your insurer.
Compounded Tirzepatide Is a Separate Pathway
Compounded tirzepatide is not an FDA-approved finished drug. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Read the federal compounding rules and discuss the treatment decision with your licensed provider.
Identify the dispensing pharmacy and check its state-board record. A pharmacy license does not certify a preparation or establish that it is appropriate for an individual patient.
Clinical Trial Information
Clinical trial listings do not establish current enrollment, available treatment or compensation. Read the specific study details at ClinicalTrials.gov; a listing is not a promise of access.
Insurance and Program Requirements
Check current plan documents, the covered product and indication, and any prior authorization or savings-program requirements. General information from the Centers for Medicare & Medicaid Services does not confirm coverage for a particular patient or prescription.
Compare the Full Terms of a Care Plan
- Check the full amount due, the billing period and any payment commitment. An effective monthly amount for a prepaid term is not a monthly installment.
- Confirm what the quote includes and whether consultation, medication, supplies, shipping or other services are charged separately.
- Read renewal, cancellation and refund conditions before enrolling. Check whether turning off renewal affects the current paid term.
Get Compounded Tirzepatide Through Trimi
Review the selected plan's amount due, commitment, renewal and refund conditions before paying. A licensed provider determines whether to prescribe. Compounded medications are not FDA-approved.
Tirzepatide cost: buyer questions
Does a monthly equivalent mean I am charged each month?
No. A monthly equivalent divides a prepaid term's full charge by its number of months. Trimi's annual plan is billed upfront for a 12-month commitment. Review the amount due and selected term at checkout.
Does the price increase when my prescribed dose changes?
Each Trimi plan includes medication if prescribed, injection supplies, provider access and shipping, with no separate enrollment, consultation, membership or shipping fee. The price is the same at every prescribed dose. A licensed provider decides whether to prescribe. Compounded medications are not FDA-approved.
What renewal and refund terms should I read?
Check the full charge, paid term, renewal, cancellation and refund conditions before choosing a plan. Monthly and quarterly plans renew automatically unless renewal is turned off. Ask Support to confirm continuation and future billing for a 6-month or annual plan. Turning off renewal does not refund a term already paid for. If a licensed provider determines treatment is not appropriate, the order is refunded in full under the refund policy.
Related Articles
Related Articles
Tirzepatide vs Semaglutide: Which is Right for You?
Comprehensive comparison of the two leading GLP-1 medications for weight loss, including effectiveness, side effects, and cost.
Read moreCompounded Compounded Tirzepatide Cost Guide
What compounded tirzepatide costs, what the flat rate includes, and how billing works.
Read moreWeight Loss Injection Costs Compared
Complete price comparison of all major weight loss injections including semaglutide, tirzepatide, and other options.
Read moreRelated Reading
Background References
These background references do not verify current prices, insurance benefits or offer terms.
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.